Direkt zum Inhalt
Merck
Alle Fotos(3)

Wichtige Dokumente

Gesamtdokumentation anzeigen

G9259

Sigma-Aldrich

α-Glucosidase from rice

greener alternative

Type V, ammonium sulfate suspension, 40-80 units/mg protein

Synonym(e):

Maltase

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Größe auswählen

100 UNITS
€ 243,00

€ 243,00

Check Cart for Availability
Alle Fotos(3)

Größe auswählen

Ansicht ändern
100 UNITS
€ 243,00

About This Item

CAS-Nummer:
9001-42-7
EC-Nummer:
3.2.1.20 (BRENDA, IUBMB)
EG-Nummer:
232-604-7
MDL-Nummer:
MFCD00081321
UNSPSC-Code:
12352204
NACRES:
NA.54

€ 243,00

Check Cart for Availability

Typ

Type V

Qualitätsniveau

200

Form

ammonium sulfate suspension

Spezifische Aktivität

40-80 units/mg protein

Grünere Alternativprodukt-Eigenschaften

Waste Prevention
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

sustainability

Greener Alternative Product

Grünere Alternativprodukt-Kategorie

Enabling,

Lagertemp.

2-8°C

Allgemeine Beschreibung

We are committed to bringing you Greener Alternative Products, which adhere to one or more of The 12 Principles of Greener Chemistry. This product has been enhanced for energy efficiency and waste prevention when used in starch hydrolysis research. For more information see the article in biofiles.

Einheitendefinition

One unit will convert 1.0 μmole of maltose to 2.0 μmoles of D-glucose per min at pH 4.0 at 37 °C.

Physikalische Form

Suspension in 2.8 M (NH4)2SO4 solution

Hinweis zur Analyse

Protein determined by biuret.

Sonstige Hinweise

View more information on enzymes for complex carbohydrate analysis at www.sigma-aldrich.com/enzymeexplorer

Inhibitor

Produkt-Nr.
Beschreibung
Preisangaben

Substrat

Produkt-Nr.
Beschreibung
Preisangaben

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

Eyeshields, Gloves, type N95 (US)

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number
0000348193
0000349929
0000173532
0000164566
079M4105V

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Suche nach COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Michael D Rugen et al.
Methods in molecular biology (Clifton, N.J.), 1795, 101-115 (2018-05-31)
The hydrolysis of starch is a key step in plant germination, which also has relevance in the malting and brewing processes for beer and spirit production. Gaps in knowledge about this metabolic process exist that cannot easily be addressed using
Rachel Mata et al.
Journal of natural products, 76(3), 468-483 (2013-02-13)
Type II-diabetes mellitus (TII-DM) has been regarded as one of the most important public health problems in all nations in the 21st century. Although allopathic therapies remain the most important for the initial management of TII-DM, herbal remedies have gained
Shinji Onose et al.
Food chemistry, 138(1), 516-523 (2012-12-26)
1-Deoxynojirimycin (DNJ), a potent α-glycosidase inhibitor, has therapeutic applications in treatments of HIV, Gaucher's disease, and diabetes. DNJ has been extracted from natural sources (mulberry leaves) for therapeutic purposes; however, DNJ ingredients are in limited supply and are costly to
Thomas J Conlon et al.
Human gene therapy. Clinical development, 24(3), 127-133 (2013-09-12)
A biodistribution and toxicology study was performed to test the acute toxicities of intradiaphragmatic injection of a recombinant adeno-associated virus (rAAV) 2/1-human acid alpha-Glucosidase (hGAA) driven by a cytomegalovirus (CMV) promoter (rAAV1-CMV-hGAA) in New Zealand white rabbits and in the
Nicolai Preisler et al.
Molecular genetics and metabolism, 110(3), 287-289 (2013-09-10)
Late-onset Pompe disease is a rare, but potentially treatable metabolic myopathy, and therefore should not be overlooked. However, it is not unusual that patients go undiagnosed for many years. We hypothesized that patients with late-onset Pompe disease may have been
Alle zugehörigen Dokumente anzeigen

Artikel

How to Work with Enzymes Supplied as Ammonium Sulfate Suspensions

Instructions for working with enzymes supplied as ammonium sulfate suspensions

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.